Thomas Beckers - Publications, H-index & Citations

Thomas Beckers

nycomed gmbh

35H指数

201论文数

4.8K被引数

收录论文 40

发表时间

Geometric Control for Load Transportation With Quadrotor UAVs by Elastic Cables

IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY

IF3.9

2023-11-01

OAAI

Goodman, Jacob R. R.; Beckers, Thomas; Colombo, Leonardo J. J.

Prediction With Approximated Gaussian Process Dynamical Models 基于近似高斯过程动力学模型的预测

IEEE TRANSACTIONS ON AUTOMATIC CONTROL

IF7

2022-12-01

OAAI

Beckers, Thomas; Hirche, Sandra

Stable Gaussian process based tracking control of Euler-Lagrange systems

AUTOMATICA

IF5.9

2019-05-01

OAAI

Beckers, Thomas; Kulic, Dana; Hirche, Sandra

Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2012-01-01

PREAI

Beckers, Thomas; Sellmer, Andreas; Eichhorn, Emerich; Pongratz, Herwig; Schaechtele, Christoph; Totzke, Frank; Kelter, Gerhard; Krumbach, Rebekka; Fiebig, Heinz-Herbert; Boehmer, Frank-D.; Mahboobi, Siavosh

Three-Dimensional Photonic Crystal Intermediate Reflectors for Enhanced Light-Trapping in Tandem Solar Cells

ADVANCED MATERIALS

IF26.8

2011-07-25

PREAI

Uepping, Johannes; Bielawny, Andreas; Wehrspohn, Ralf B.; Beckers, Thomas; Carius, Reinhard; Rau, Uwe; Fahr, Stefan; Rockstuhl, Carsten; Lederer, Falk; Kroll, Matthias; Pertsch, Thomas; Steidl, Lorenz; Zentel, Rudolf

Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance

EUROPEAN JOURNAL OF CANCER

IF7.1

2011-05-01

121

PREAI

Krumbach, Rebekka; Schueler, Julia; Hofmann, Michael; Giesemann, Torsten; Fiebig, Heinz-Herbert; Beckers, Thomas

In vitro profiling of gastric and liver cancer cell lines developed from Asian cancer patients

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Kelter, Gerhard; Maier, Armin; Krumbach, Rebekka; Schueler, Julia; Fiebig, Heinz-Herbert; Beckers, Thomas

In vitro profiling of kinase inhibitors and targeted anticancer agents in panels of patient-derived xenografts using a clonogenic assay

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Maier, Armin; Metz, Thomas; Krumbach, Rebekka; Beckers, Thomas; Fiebig, Heinz-Herbert

Expression of Hedgehog pathway molecules in patient-derived pancreatic adenocarcinoma xenograft models

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Vuarogueaux, Vincent; Misters, Simon; Fiebig, Heinz-Herbert; Foucault, Frederic; Beckers, Thomas

MET inhibitor sensitivity and resistance

CANCER RESEARCH

IF16.6

2011-04-01

PREAI

Krumbach, Rebekka; Kelter, Gerhard; Maier, Armin; Fiebig, Heinz-Herbert; Beckers, Thomas

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2010-11-16

108

PREAI

Mahboobi, Siavosh; Sellmer, Andreas; Winkler, Matthias; Eichhorn, Emerich; Pongratz, Herwig; Ciossek, Thomas; Baer, Thomas; Maier, Thomas; Beckers, Thomas

Comparison and optimization of randomly textured surfaces in thin-film solar cells

OPTICS EXPRESS

IF3.3

2010-08-03

139

OAAI

Rockstuhl, C.; Fahr, S.; Bittkau, K.; Beckers, T.; Carius, R.; Haug, F. -J.; Soederstroem, T.; Ballif, C.; Lederer, F.

Molecular characterization of a panel of patient-derived breast cancer xenografts

CANCER RESEARCH

IF16.6

2010-04-01

PREAI

Giesemann, Torsten; Krumbach, Rebekka; Schiller, Julia; Vuaroqueaux, Vincent; Hofmann, Michael; Liu, Ningshu; Haegebarth, Andrea; Beckers, Thomas; Fiebig, Heinz-Herbert

Testing a gene expression based signature predicting Cetuximab sensitivity in wild type KRAS tumors expressing EGFR

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Vuaroqueaux, Vincent; Korrat, Andre; Jean-Denis, Myriam; Schuler, Julia; Hofmann, Michael; Beckers, Thomas; Fiebig, Heinz-Herbert

Profiling of targeted anticancer agents in a panel of 48 patient-derived xenografts using a clonogenic assay

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Maier, Armin; Metz, Thomas; Hofmann, Michael; Krumbach, Rebekka; Fiebig, Heinz-Herbert; Beckers, Thomas

A collection of patient-derived pancreatic adenocarcinoma xenograft models: Chemosensitivity in vitro and in vivo and molecul characterization

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Beckers, Thomas; Maier, Armin; Schuler, Julia; Hofmann, Michael; Giesemann, Torsten; Hopt, Ulrich; Keck, Tobias; Fiebig, Heinz-Herbert; Kusters, Simon

In vitro profiling of traditional tubulin targeting and new antimitotic compounds by using a 40 cancer cell line panel in combination with Compare Analysis

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Kelter, Gerhard; Metz, Thomas; Korrat, Andre; Giesemann, Torsten; Fiebig, Heinz -Herbert; Beckers, Thomas

MET activation and Cetuximab resistance in patient-derived tumor xenografts

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Krumbach, Rebekka; Schuler, Julia; Hofmann, Michael; Fiebig, Heinz-Herbert; Beckers, Thomas

TriN 2755: Antitumor activity of a new cytotoxic therapeutic of the triazene class

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Bausch, Niko; Baltes, Steffen; Fiebig, Heinz-Herbert; Beckers, Thomas; Barth, Wolfgang

Signal pathway profiling of cancer cell lines derived from serially passaged human tumorgrafts for guiding drug development

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-12-01

PREAI

Yang, Feng; Li, Yue; Aggarwal, Amit; Manro, Jason; Li, Shuyu Dan; Donoho, Greg; Kelter, Gerhard; Beckers, Thomas; Fiebig, Heinz-Herbert; Yingling, Jonathan M.; Tucker-Kellogg, Greg; Stancato, Louis

研究方向